Literature DB >> 26181625

Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer.

W Dang1, H Tang1, H Cao1, L Wang1, X Zhang1, W Tian1, X Pang1, K Li1, T Chen1.   

Abstract

Recent studies underscore the importance of crosstalk between tumor-associated macrophages (TAMs) and tumor cells in cancer progression and metastasis. In our study, AdCD68STAT3β, a recombinant adenovirus containing a STAT3β gene driven by CD68 macrophage-specific promoter, was used to suppress STAT3 and the downstream signaling pathways in TAMs. The results showed that STAT3β gene under the control of CD68 macrophage-specific promoter was only expressed in macrophages, which significantly inhibited the motility and invasion of breast cancer cells when co-cultured with 4T1 cells. Moreover, cell-specific STAT3β expression in TAMs extended survival of tumor-bearing mice and suppressed breast tumor growth, angiogenesis and metastasis, by regulating the crosstalk between tumor cells and TAMs. Therefore, our study provided a novel strategy for the antitumor effects of STAT3β.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26181625     DOI: 10.1038/gt.2015.70

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  29 in total

1.  Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.

Authors:  Xian-zong Ye; Sen-lin Xu; Yan-hong Xin; Shi-cang Yu; Yi-fang Ping; Lu Chen; Hua-liang Xiao; Bin Wang; Liang Yi; Qing-liang Wang; Xue-feng Jiang; Lang Yang; Peng Zhang; Cheng Qian; You-hong Cui; Xia Zhang; Xiu-wu Bian
Journal:  J Immunol       Date:  2012-06-04       Impact factor: 5.422

2.  Development of a synthetic promoter for macrophage gene therapy.

Authors:  Weijing He; Mei Qiang; Wuqiong Ma; Anthony J Valente; Marlon P Quinones; Wen Wang; Robert L Reddick; Qifu Xiao; Seema S Ahuja; Robert A Clark; Gregory L Freeman; Senlin Li
Journal:  Hum Gene Ther       Date:  2006-09       Impact factor: 5.695

3.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.

Authors:  Jinyong Luo; Zhong-Liang Deng; Xiaoji Luo; Ni Tang; Wen-Xin Song; Jin Chen; Katie A Sharff; Hue H Luu; Rex C Haydon; Kenneth W Kinzler; Bert Vogelstein; Tong-Chuan He
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 4.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

5.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Authors:  Jiehui Deng; Yong Liu; Heehyoung Lee; Andreas Herrmann; Wang Zhang; Chunyan Zhang; Shudan Shen; Saul J Priceman; Maciej Kujawski; Sumanta K Pal; Andrew Raubitschek; Dave S B Hoon; Stephen Forman; Robert A Figlin; Jie Liu; Richard Jove; Hua Yu
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

Review 6.  Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Authors:  Hua Yu; Marcin Kortylewski; Drew Pardoll
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

7.  Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells.

Authors:  Guotai Xu; Cai Zhang; Jian Zhang
Journal:  Mol Med Rep       Date:  2009 Sep-Oct       Impact factor: 2.952

Review 8.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

9.  A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

Authors:  Shicheng Su; Qiang Liu; Jingqi Chen; Jianing Chen; Fei Chen; Chonghua He; Di Huang; Wei Wu; Ling Lin; Wei Huang; Jin Zhang; Xiuying Cui; Fang Zheng; Haiyan Li; Herui Yao; Fengxi Su; Erwei Song
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

Review 10.  A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition.

Authors:  Yukio Fujiwara; Motohiro Takeya; Yoshihiro Komohara
Journal:  Biomed Res Int       Date:  2014-03-11       Impact factor: 3.411

View more
  5 in total

Review 1.  STAT3 activation in infection and infection-associated cancer.

Authors:  Rong Lu; Yong-Guo Zhang; Jun Sun
Journal:  Mol Cell Endocrinol       Date:  2017-02-20       Impact factor: 4.102

2.  STAT3β is a tumor suppressor in acute myeloid leukemia.

Authors:  Petra Aigner; Tatsuaki Mizutani; Jaqueline Horvath; Thomas Eder; Stefan Heber; Karin Lind; Valentin Just; Herwig P Moll; Assa Yeroslaviz; Michael J M Fischer; Lukas Kenner; Balázs Győrffy; Heinz Sill; Florian Grebien; Richard Moriggl; Emilio Casanova; Dagmar Stoiber
Journal:  Blood Adv       Date:  2019-07-09

Review 3.  Macrophage-based cell therapies: The long and winding road.

Authors:  Simon Lee; Saul Kivimäe; Aaron Dolor; Francis C Szoka
Journal:  J Control Release       Date:  2016-07-12       Impact factor: 9.776

Review 4.  The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.

Authors:  Agnieszka Witalisz-Siepracka; Klara Klein; Bernhard Zdársky; Dagmar Stoiber
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

5.  STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS.

Authors:  Morten N Andersen; Niels F Andersen; Kristina L Lauridsen; Anders Etzerodt; Boe S Sorensen; Niels Abildgaard; Trine Plesner; Marianne Hokland; Holger J Møller
Journal:  Cancer Immunol Immunother       Date:  2021-06-01       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.